A RANDOMIZED CONTROLLED STUDY OF ITRACONAZOLE IN CHRONIC CAVITARY PULMONARY ASPERGILLOSIS (ITRACONASP)

NCT01259336 Phase 4 COMPLETED

The purpose of this study is to determine whether there itraconazole is effective in the treatment of chronic cavitary pulmonary aspergillosis

Details

Lead sponsor	Post Graduate Institute of Medical Education and Research, Chandigarh
Phase	Phase 4
Status	COMPLETED
Enrolment	31
Start date	2010-07
Completion	2011-12

Conditions

• Chronic Cavitary Pulmonary Aspergillosis

Interventions

• Itraconazole
• treatment in cavitary pulmonary aspergillosis

Primary outcomes

• clinical improvement in cough and hemoptysis — 6 months
  Clinical response- assessed by a decrease in frequency \& intensity of hemoptysis \& cough. Significant clinical response will be considered if there is no recurrence of episodes of moderate-massive hemoptysis. Number of interventions required to control hemoptysis will also be taken as a measure of clinical response

Countries

India